InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| THP1-Blue™ ISG Cells | Discovery of triazoloquinoxaline as novel STING agonists via structure-based ... | 2020 | Bioorg Chem. | Hou H. et al. | DOI: 10.1016/j.bioorg.2020.103958 |
| ODN M362 - TLR9 ligand | Exposure of Intestinal Epithelial Cells to 2'-Fucosyllactose and CpG Enhances... | 2020 | Biomolecules. | Ayechu-Muruzabal V. et al. | DOI: 10.3390/biom10050784 |
| CL097 | In-depth characterization of monocyte subsets during the course of healthy pr... | 2020 | J Reprod Immunol | Pflitsch C. et al. | DOI: 10.1016/j.jri.2020.103151 |
| U0126 | Glycolytic inhibitor 2-deoxyglucose suppresses inflammatory response in innat... | 2020 | Exp Eye Res | Francis R. et al. | DOI: 10.1016/j.exer.2020.108079 |
| HepG2-Lucia™ AhR Cells | Discovery of 2-aryl and 2-pyridinylbenzothiazoles endowed with antimicrobial ... | 2020 | Eur J Pharm Sci | Goya-Jorge E. et al. | DOI: 10.1016/j.ejps.2020.105386 |
| THP-1 Lucia Reporter Cells (NF-κB) | Foam Cells Control Mycobacterium tuberculosis Infection. | 2020 | Front Microbiol | Agarwal P. et al. | DOI: 10.3389/fmicb.2020.01394. |
| pCpGfree | Altered PTPRD DNA methylation associates with restricted adipogenesis in heal... | 2020 | Epigenomics | Parrillo L. et al. | DOI: 10.2217/epi-2019-0267 |
| Anti-β-Gal-IgA2 isotype control | IGF1R is an entry receptor for respiratory syncytial virus. | 2020 | Nature | Griffiths CD. et al. | DOI: 10.1038/s41586-020-2369-7. |
| Anti-hTLR4 Neutralizing mAb | IGF1R is an entry receptor for respiratory syncytial virus. | 2020 | Nature | Griffiths CD. et al. | DOI: 10.1038/s41586-020-2369-7. |
| Anti-hTLR2 Detection and Neutralizing mAb | IGF1R is an entry receptor for respiratory syncytial virus. | 2020 | Nature | Griffiths CD. et al. | DOI: 10.1038/s41586-020-2369-7. |
| Recombinant human CD40L protein (E. coli) - Bioactive cytokine | TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune ... | 2020 | Int Immunopharmacol. | Zou Z. et al. | DOI: 10.1016/j.intimp.2020.106648 |
| LumiKine™ Xpress hIFN-β 2.0 | RIG-I Plays a Dominant Role in the Induction of Transcriptional Changes in Zi... | 2020 | Cells | Schilling M. et al. | DOI: 10.3390/cells9061476 |
| CD 80 | Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens... | 2020 | Adv Mater. | Jiang Y. et al. | DOI: 10.1002/adma.202001808 |
| Recombinant human IL-1β protein (E. coli) - Bioactive cytokine | Mice Lacking the Purinergic Receptor P2X5 Exhibit Defective Inflammasome Acti... | 2020 | J Immunol | Jeong Y.J. et al. | DOI: 10.4049/jimmunol.1901423 |
| Recombinant human IL-18 protein - Bioactive cytokine | Mice Lacking the Purinergic Receptor P2X5 Exhibit Defective Inflammasome Acti... | 2020 | J Immunol | Jeong Y.J. et al. | DOI: 10.4049/jimmunol.1901423 |
| Nigericin | Mice Lacking the Purinergic Receptor P2X5 Exhibit Defective Inflammasome Acti... | 2020 | J Immunol | Jeong Y.J. et al. | DOI: 10.4049/jimmunol.1901423 |
| pFUSE-mIgG1-Fc | A potent antagonist antibody targeting connexin hemichannels alleviates Clous... | 2020 | EBioMedicine | Kuang Y. et al. | DOI: 10.1016/j.ebiom.2020.102825 |
| pFUSE-hIgG1-Fc | A potent antagonist antibody targeting connexin hemichannels alleviates Clous... | 2020 | EBioMedicine | Kuang Y. et al. | DOI: 10.1016/j.ebiom.2020.102825 |
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | E. coli-Produced Monophosphoryl Lipid a Significantly Enhances Protective Imm... | 2020 | Vaccines (Basel) | Nguyen QT. et al. | DOI: 10.3390/vaccines8020306 |
| TLR4 agonist preparation - MPLA-SM | E. coli-Produced Monophosphoryl Lipid a Significantly Enhances Protective Imm... | 2020 | Vaccines (Basel) | Nguyen QT. et al. | DOI: 10.3390/vaccines8020306 |